Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA chief of staff

Executive Summary

FDA appoints Susan Winckler as acting chief of staff. Winckler replaces Patrick Ronan who was chief of staff since August 2005. Before joining FDA as director for policy communications, Winckler served as VP of policy and communications for the American Pharmacists Association (1"The Pink Sheet" Sept. 18, 2006, In Brief). Winckler will begin her new role in early January...

You may also be interested in...

FDA Re-Org Makes Chief Of Staff Liaison Between Centers And Commissioner

A newly created FDA Office of the Chief of Staff will serve as the major point of contact between FDA centers and offices, and the Commissioner, according to an Aug. 30 Federal Register notice

FDA fills new position with APhA exec

FDA appoints American Pharmacists Association VP-Policy & Communications Susan Winckler to the new position of director for policy communications. Winckler will have primary responsibility for developing and implementing advisory committee policy and will help coordinate public participation in FDA policymaking. Winckler represented APhA in Prescription Drug User Fee Act reauthorization discussions (1"The Pink Sheet" Nov. 28, 2005, p. 11)...

EU’s SCCS Finds Endocrine-Disrupting Evidence Inconclusive In UV Filter Reassessments

While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts